Eton Pharmaceuticals: Specialty Medications as a Growth Guarantee

Eton Pharmaceuticals bypasses the expensive failures of traditional drug research by optimizing and exclusively marketing established medications for rare pediatric and metabolic diseases. As new products are sold through the existing distribution network to the same specialist physicians, revenues increase significantly faster than operating costs. The company has successfully transitioned into profitability and aims for long-term EBITDA margins of over 50% through organic product additions and targeted acquisitions. Eton Pharmaceuticals...